AVP receptor antagonists in patients with CHF
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s10741-008-9107-9.pdf
Reference11 articles.
1. Gheorghiade M, Gattis WA, O’Connor CM, Adams KF, Jr, Elkayam, U, for the ACTIV in CHF investigators (2004) Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. J Am Med Assoc 291: 1963–1971. doi: 10.1001/jama.291.16.1963
2. Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Orlandi C, Tolvaptan investigators (2003) Vasopressin receptor blockade in patients with congestive heart failure: results from a randomized, double-blind study. Circulation 107:2690–2696. doi: 10.1161/01.CIR.0000070422.41439.04
3. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. New Engl J Med 355:2099–2112, number 20
4. Udelson JE, McGrew F, Flores E, Ibrahim H, Katz S, Koshkarian G, O’Brien T, Konstam M (2007) Multicenter randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol 49(22):2151–2159
5. Konstam MA, Gheorghiade M, Burnett JC, Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, for the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) investigators (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure. J Am Med Assoc 297:1319–1331. Published online March 25, 2007. doi: 10.1001/jama.297.12.1319
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Redefining biomarkers in heart failure;Heart Failure Reviews;2018-03
2. Synthesis and biological evaluation of novel phenothiazine derivatives as non-peptide arginine vasopressin V2 receptor antagonists;Chinese Chemical Letters;2015-05
3. Synthesis and biological evaluation of novel derivatives of desloratadine;Chinese Chemical Letters;2013-06
4. Emerging Biomarkers in Heart Failure;Clinical Chemistry;2012-01-01
5. Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers;Biomarkers;2011-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3